#3DStartup: FemTherapeutics Improves Women’s Health With Personalized Treatment

At the heart of the dynamic healthcare innovation sector, Montreal-based startup FemTherapeutics is positioning itself as a driver of change in women’s health, offering personalized solutions. Specializing in the treatment of pelvic organ prolapse (POP), the company sets itself apart by developing 3D-printed pessaries, perfectly tailored to each patient’s individual needs. We spoke to the company to find out more about its background, methods and future projects. Vincent Castonguay-Siu, head of engineering research and development, told us more about the company’s beginnings, the use of 3D printing technology in this sector and the innovative potential of the startup’s approach.

3DN: Could you introduce yourself and your connection to 3D printing?

Vincent Castonguay-Siu, Head of Engineering R&D at FemTherapeutics.

FemTherapeutics is dedicated to revolutionizing women’s health by offering personalized treatment for a condition called pelvic organ prolapse. To this end, we design 3D-printed pessaries specifically tailored to each patient. This customization is based on anatomical and pathological data integrated into our models, enabling us to optimize the shape of the device for each individual.

I’m Vince, head of mechanical engineering research and development at FemTherapeutics. With an M.Sc. in Biomedical Engineering from ETH Zurich, I have seven years’ experience in design and manufacturing, particularly in the field of medical devices. My achievements have been rewarded on several occasions for their design and innovation, both nationally and internationally.